SIRI as a biomarker for bladder neoplasm: Utilizing decision curve analysis to evaluate clinical net benefit
SIRI is an innovative prognostic indicator and a potential biomarker that can enhance conventional medical pathological evaluation and improve the personalization of clinical treatment strategies for bladder cancer patients following RC.
Authors
- Francesco Pio Bizzarri (ORCID: https://orcid.org/0000-0003-2119-9023)
- Stefano Moretto (ORCID: https://orcid.org/0000-0003-3418-5202)
- Nazario Foschi (ORCID: https://orcid.org/0000-0003-0464-0788)
- Filippo Marino (ORCID: https://orcid.org/0000-0002-2908-6907)
- Chiara Ciccarese (ORCID: https://orcid.org/0000-0002-3283-4339)
- Mauro Ragonese (ORCID: https://orcid.org/0000-0002-1919-8729)
- Bernardo Rocco (ORCID: https://orcid.org/0000-0002-9135-0035)
- C. Gandi
- Marco Racioppi (ORCID: https://orcid.org/0000-0001-9129-8479)
- Giovanni Battista Filomena (ORCID: https://orcid.org/0009-0005-8884-6573)
- Emilio Sacco (ORCID: https://orcid.org/0000-0003-4640-8354)
- Roberto Iacovelli (ORCID: https://orcid.org/0000-0002-1750-2117)
- Filippo Gavi (ORCID: https://orcid.org/0000-0001-9994-4316)
- Giuseppe Palermo (ORCID: https://orcid.org/0000-0002-3861-3545)
- Maria Chiara Sighinolfi (ORCID: https://orcid.org/0000-0001-7211-0485)
- Savio Domenico Pandolfo (ORCID: https://orcid.org/0000-0001-9621-3059)
- Pierluigi Russo (ORCID: https://orcid.org/0000-0002-7789-9486)
- Giuseppe Maioriello
- Nicolò Lentini (ORCID: https://orcid.org/0009-0008-3111-1535)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Humanitas University (IT)
- University of L'Aquila (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2025-02-11
- DOI
- https://doi.org/10.1016/j.urolonc.2025.01.007
- Citations
- 27
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 54.17